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Likely Better, But Not Yet a Mandate*Robert A. Guyton, MDT here is increasingly compelling evidence ofthe advantages of multiple arterial bypassgrafting compared with the use of a single
arterial conduit (1–4). In this issue of the Journal, Habib
et al. (5) have made another contribution to the weight
of this evidence. There are, however, concerning limi-
tations to this single-institution retrospective study.SEE PAGE 1417As we evaluate the weight that should be given to
this study, we must ask 2 critical questions. First,
what were the patient-speciﬁc pathologic factors that
determined the choice of revascularization proce-
dure? Were these patient-speciﬁc factors appropri-
ately measured and recorded to allow reasonable risk
adjustment of the 4 groups compared? Second, is the
single institution sufﬁciently representative that the
conclusions of this study are applicable elsewhere?
The study was conducted at the Beth Israel Medical
Center in New York. This is an institution with a long
tradition of excellent coronary revascularization,
with superb results over the past quarter century
(6,7). Surgeons at this institution have been cham-
pions of the radial artery as a second arterial graft. As
percutaneous coronary intervention (PCI) emerged,
the superior PCI practitioners at the Mount Sinai
family of hospitals aggressively pursued off-label
stenting for multivessel coronary disease. Stenting
became the default therapy for multivessel disease.
In the patients eligible for this retrospective study,
we must be honest about the factors that determined*Editorials published in the Journal of the American College of Cardiology
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served as Guest Editor for this paper.the choice of revascularization procedures. Especially
after drug-eluting stent availability, multivessel
stentingwas performed inmost patients inwhom a PCI
could accomplish substantial revascularization. This
fact is conﬁrmed by the data that the authors present.
In the 11 years from which the PCI data were derived,
417 multivessel study–eligible patients on average per
year underwent PCI. In the 17 years of coronary
bypass grafting (CABG) data collection, 224 patients on
average per year underwent CABG and approximately
30% of these had left main artery disease. This means
that in this institution more than twice as many mul-
tivessel, non–left main artery patients underwent
multivessel PCI as CABG. This very aggressive use of
multivessel stenting was dramatically higher than the
use of multivessel stenting in the State of New York
reported for bare metal stenting (1997 to 2000) and for
drug-eluting stents (2003 to 2004) (8,9).
Review of the study’s demographic data reveals
that the choice of patients for stenting versus CABG
was determined primarily by the extent of coronary
disease. The real difﬁculty with the data collected is
that the speciﬁc coronary pathology that determined
the use of stenting, single-artery grafting or multiple-
artery grafting, was neither measured nor recorded
in the data available for statisticians to make ap-
propriate adjustments. The data collected did not
distinguish between easily stentable coronary pa-
thology, arteries appropriate for a second arterial
graft, and arteries not appropriate for a second arte-
rial graft. These granular data on coronary patho-
logy are most important. The triple-vessel cohort
of SYNTAX (Synergy between PCI with Taxus and
Cardiac Surgery) demonstrated that progressively
advanced coronary disease treated by either PCI or
CABG is associated with progressively increasing in-
termediate and late mortality (10).
We are left then with 3 important facts. First, the
most discriminating factor in the choice of revascu-
larization procedure was not recorded. Second, this
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1429important factor is strongly associated with interme-
diate and long-term mortality. Third, as the data
collected (double-vessel vs. triple-vessel vs. left main
artery disease) only minimally reﬂect this important
factor, no amount of statistical gymnastics can reli-
ably adjust for this missing variable.
Habib and colleagues got it right as they describe
the limitations of their study: “Our study ﬁndings are
based on a retrospective analysis of PCI and CABG
data from a single institution, which may limit their
generalizability. Propensity matching may not have
accounted for unmeasured confounders.” They sub-
sequently make a quite zealous conclusion, implying
that their data are the source of this conclusion.
Their analysis is substantially confounded by a strong
institutional preference for multivessel stenting, by
the absence of sufﬁcient granular data on the extent
of atherosclerotic coronary artery disease, and by
the institutional policy of steering patients younger
than 65 years of age with speciﬁc anatomy suitable
for radial artery grafting to multiple arterial cor-
onary bypass grafting. I believe that the conclusion is
correct, but it is justiﬁed by the weight of evidence
from multiple studies, not the data and analysis
presented.
The authors pointed out that their ﬁndings are
limited in generalizability. I would argue that the
generalizability of techniques in coronary artery
revascularization is both a problem and an opportu-
nity. When we are dealing with medical procedures
that are often highly technical with outcomes depen-
dent on both operator skill and technique-speciﬁc
experience, there should not be a huge attempt to
generalize the procedure pathway. We seek to provide
the best procedure for the speciﬁc patient, for the
speciﬁc pathophysiology, and in the speciﬁc circum-
stance in which the decision must be made. This
circumstance includes knowledge of local outcomes
with various procedures. Shared decision making in
the case of medical interventions that are experience
and skill dependent includes accommodation of the
expertise and preferences of the operators who are
available to perform those interventions.Consider an illustrative example: the ERACI-II trial
reported a 5.7% 30-day mortality rate for CABG and a
0.9% mortality rate for PCI (11). These outcomes are
very different from the equivalent CABG/PCI mortal-
ity in the current study. If I had multivessel disease
and found myself in one of the ERACI-II hospitals at
that time, please allow me to choose PCI. If I am in the
Beth Israel Medical Center and my pathology is suit-
able for either PCI or single or multiple arterial coro-
nary bypass, please let me have multiple arterial
coronary bypass. Shared decision making includes an
understanding of the skill and the expertise and the
outcomes that are reasonably available to the patient
if an intervention is being considered. We know this.
We rarely verbalize it.
In summary, these authors have added to the
weight of evidence favoring multiple arterial bypass
grafting. They appropriately state limitations. As
these limitations are considerable, the conclusions
are overly zealous and might best be restated as fol-
lows: “Our experience is consistent with other studies
indicating that survival for revascularization from
coronary artery bypass including at least 1 arterial
graft is superior to survival after multivessel stenting
except in the earliest stages of multivessel disease.
Our data indicate that a second arterial graft in pa-
tients younger than 65 years of age confers a partic-
ular survival advantage compared with multivessel
stenting when using bare-metal or drug-eluting
stents. At our institution, we have found the radial
artery to be an effective second arterial conduit when
applied to a second arterial target with at least a
70% proximal stenosis.” This conclusion more accu-
rately reﬂects the state of the art.
Take heart, readers! There is a prospective, ran-
domized study that will shortly help illuminate this
issue. Professor David Taggart’s ART study of single
versus multiple arterial coronary grafting has
completed enrollment and is eagerly anticipated (12).
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